{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:21:41Z","timestamp":1762867301711},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.imlet.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T21:16:21Z","timestamp":1510866981000},"page":"11-13","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome"],"prefix":"10.1016","volume":"193","author":[{"given":"Giovanni M.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Adorni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Alberici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Bodria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian M.","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.imlet.2017.11.002_bib0005","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00467-016-3509-z","article-title":"Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?","volume":"31","author":"Dossier","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.002_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska","year":"2017","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.002_bib0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.002_bib0020","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"Maas","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1-2","key":"10.1016\/j.imlet.2017.11.002_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/pr.2016.200","article-title":"Idiopathic nephrotic syndrome: the EBV hypothesis","volume":"81","author":"Dossier","year":"2017","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.002_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","article-title":"Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome","volume":"17","author":"Kemper","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imlet.2017.11.002_bib0035","series-title":"Janeway's Immunobiology","first-page":"432","article-title":"The humoral immune response","year":"2016"},{"issue":"12","key":"10.1016\/j.imlet.2017.11.002_bib0040","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nm.3709","article-title":"Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes","volume":"20","author":"Clatworthy","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.002_bib0045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imlet.2017.11.002_bib0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000081447","article-title":"A note on inference of trait associations with SNP haplotypes and other attributes in generalized linear models","volume":"57","author":"Burkett","year":"2004","journal-title":"Hum. Hered."},{"key":"10.1016\/j.imlet.2017.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-1","article-title":"A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer","volume":"6","author":"Mellor","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.002_bib0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2017.11.002_bib0065","doi-asserted-by":"crossref","first-page":"31617","DOI":"10.1038\/srep31617","article-title":"Comprehensive assessment of the association between FCGRs polymorphisms and the risk of systemic lupus erythematosus: evidence from a meta-analysis","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.11.002_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2875-7-13","article-title":"C. Indian Genome Variation, V., Venkatesh, S., Habib, Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population","volume":"7","author":"Sinha","year":"2008","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.002_bib0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jmg.2009.073643","article-title":"FCGR2A functional genetic variant associated with susceptibility to severe malarial anaemia in Ghanaian children","volume":"47","author":"Schuldt","year":"2010","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.002_bib0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.ejhg.5201285","article-title":"Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis","volume":"13","author":"De Rose","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"issue":"19","key":"10.1016\/j.imlet.2017.11.002_bib0085","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1158\/0008-5472.CAN-06-0324","article-title":"Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.002_bib0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.002_bib0095","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-15-0414","article-title":"Fc-gamma receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer","volume":"22","author":"Liu","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.imlet.2017.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2217\/pgs.16.27","article-title":"Associations between functional FCGR2A R131H and FCGR3A F158 V polymorphisms and responsiveness to TNF blockers in spondyloarthropathy, psoriasis and Crohn's disease: a meta-analysis","volume":"17","author":"Lee","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.002_bib0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00296-016-3476-5","article-title":"Associations between PTPRC rs10919563A\/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis","volume":"36","author":"Lee","year":"2016","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imlet.2017.11.002_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2305","article-title":"FCGR3A\/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts","author":"Ghesquieres","year":"2016","journal-title":"Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.002_bib0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-15-1848","article-title":"Fc gamma receptor 3A and 2A polymorphisms do not predict response to rituximab in follicular lymphoma","volume":"22","author":"Kenkre","year":"2016","journal-title":"Clin. Cancer Res."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T01:01:03Z","timestamp":1535245263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817303966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"alternative-id":["S0165247817303966"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}